ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2043

Large Joint Arthritis in Systemic Lupus Erythematosus Is Characterized by TH17 Cells Rather Than B Cell Accumulation

Natalie Sippl1, Francesca Faustini 1, Karine Chemin 1, Iva Gunnarsson 2 and Vivianne Malmström 3, 1Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, 2Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Institutet, Stockholm, Sweden., Stockholm, Sweden

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE), T cells and arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Arthritis is a common clinical feature of systemic lupus erythematosus (SLE), that can be present either at the onset or in later disease course. SLE-related arthritis is usually non-erosive and non-deforming as opposed to rheumatoid arthritis (RA). While RA synovial pathology has been extensively studied, little is known about the pathophysiology of arthritis in SLE. Here, we aimed to explore the cytokine and cellular compartments in synovial fluids (SF) of SLE patients with arthritic manifestations.

Methods: Paired synovial fluid mononuclear cells (SFMC) from large joint aspiration and peripheral blood samples (PBMC) from three SLE patients were analyzed by three different lineage-specific multicolor flow cytometry panels for B cells and T cells (cytotoxic and helper). SLE-derived SFMCs were further stimulated in vitro to measure T cell production of IFN gamma and IL-17. Since the majority of SF samples from SLE patients were not cellular, we analyzed the acellular SF samples (n=19) with cytokine bead array for Th1, Th17 and Th2 associated cytokines (BD Bioscience). The patients fulfilled the ACR 1982 classification criteria for SLE. Clinical records were reviewed in order to exclude the presence of comorbidities such osteoarthritis or overlap with RA.

Results: The overall frequency of CD4+ and CD8+ T cells among CD3+ T cells was similar across SFMC and PBMC samples, while CD19+ cells (B-lymphocytes) were scarcely present in the joint of SLE patients as opposed to the peripheral blood. In SF, we could identify an increased frequency of CCR6+ cells among CD4+ T cells, a marker associated with Th17 cells. IL-17-production could be validated in the (CD4+CCR6+) compartment following in vitro stimulation of SFMCs. Also, a strong IFN gamma production was seen, which may originate from the increased frequency of cytotoxic EOMES+ Granzyme A+ T cells that were also recorded in the SLE-SFMC. IFN gamma was not found in the acellular synovial fluid samples, while the TH17-associated cytokines IL-17 and IL-6 were abundant.

Conclusion: Although SLE is usually considered to be a B-cell driven disease, its common clinical features like arthritis could be driven in situ by T cells, namely TH17 cells and CD4+ T cells with cytotoxic profile.


Disclosure: N. Sippl, None; F. Faustini, None; K. Chemin, None; I. Gunnarsson, None; V. Malmström, None.

To cite this abstract in AMA style:

Sippl N, Faustini F, Chemin K, Gunnarsson I, Malmström V. Large Joint Arthritis in Systemic Lupus Erythematosus Is Characterized by TH17 Cells Rather Than B Cell Accumulation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/large-joint-arthritis-in-systemic-lupus-erythematosus-is-characterized-by-th17-cells-rather-than-b-cell-accumulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/large-joint-arthritis-in-systemic-lupus-erythematosus-is-characterized-by-th17-cells-rather-than-b-cell-accumulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology